Ye‐Lin Liang

1.3k total citations
21 papers, 541 citations indexed

About

Ye‐Lin Liang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ye‐Lin Liang has authored 21 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Ye‐Lin Liang's work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (7 papers) and Cancer-related gene regulation (6 papers). Ye‐Lin Liang is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (7 papers) and Cancer-related gene regulation (6 papers). Ye‐Lin Liang collaborates with scholars based in China. Ye‐Lin Liang's co-authors include Na Liu, Ying‐Qin Li, Yin Zhao, Jun Ma, Qing‐Mei He, Shiwei He, Junyan Li, Xiao-Hong Hong, Panpan Zhang and Lei Yuan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ye‐Lin Liang

21 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ye‐Lin Liang China 12 410 304 104 78 54 21 541
Xiaozhi Lv China 12 387 0.9× 276 0.9× 97 0.9× 26 0.3× 66 1.2× 38 515
Yunhong Tian China 13 288 0.7× 197 0.6× 68 0.7× 52 0.7× 74 1.4× 21 420
Tianliang Xia China 12 241 0.6× 125 0.4× 119 1.1× 44 0.6× 81 1.5× 21 366
Hsuan-Yu Peng Taiwan 9 285 0.7× 219 0.7× 72 0.7× 29 0.4× 29 0.5× 10 368
Xinhua Xu China 9 192 0.5× 86 0.3× 122 1.2× 25 0.3× 44 0.8× 20 312
Madison Canning United States 3 142 0.3× 89 0.3× 198 1.9× 129 1.7× 63 1.2× 5 372
Yixin Liu China 9 158 0.4× 70 0.2× 173 1.7× 104 1.3× 46 0.9× 25 362
Hiroko Kitahara Japan 11 186 0.5× 102 0.3× 234 2.3× 58 0.7× 62 1.1× 17 406
М. Р. Патышева Russia 9 231 0.6× 106 0.3× 189 1.8× 299 3.8× 61 1.1× 31 525
Maosheng Cheng China 12 814 2.0× 424 1.4× 132 1.3× 61 0.8× 51 0.9× 21 901

Countries citing papers authored by Ye‐Lin Liang

Since Specialization
Citations

This map shows the geographic impact of Ye‐Lin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye‐Lin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye‐Lin Liang more than expected).

Fields of papers citing papers by Ye‐Lin Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye‐Lin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye‐Lin Liang. The network helps show where Ye‐Lin Liang may publish in the future.

Co-authorship network of co-authors of Ye‐Lin Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Ye‐Lin Liang. A scholar is included among the top collaborators of Ye‐Lin Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye‐Lin Liang. Ye‐Lin Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Zi‐Qi, Xiao‐Jiang Chen, Run‐Cong Nie, et al.. (2024). Hyperactivation of mTOR/eIF4E Signaling Pathway Promotes the Production of Tryptophan‐To‐Phenylalanine Substitutants in EBV‐Positive Gastric Cancer. Advanced Science. 11(35). e2402284–e2402284. 3 indexed citations
2.
Huang, Sheng‐Yan, Sha Gong, Yin Zhao, et al.. (2024). PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma. Nature Communications. 15(1). 5300–5300. 13 indexed citations
3.
Gong, Sha, Han Qiao, Sheng‐Yan Huang, et al.. (2024). Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4/ITGA6 translation. Oncogene. 43(38). 2868–2884. 7 indexed citations
4.
Sun, Ying, Ye‐Lin Liang, Liangfang Shen, et al.. (2024). PD-1 blockade with camrelizumab after chemoradiotherapy in nasopharyngeal carcinoma.. Journal of Clinical Oncology. 42(23_suppl). 129–129. 1 indexed citations
5.
Ma, Jun, Ying Sun, Ye‐Lin Liang, et al.. (2024). Adjuvant PD-1 blockade with camrelizumab in high-risk locoregionally advanced nasopharyngeal carcinoma (DIPPER): A multicenter, open-label, phase 3, randomized controlled trial.. Journal of Clinical Oncology. 42(17_suppl). LBA6000–LBA6000. 13 indexed citations
6.
Chen, Kailin, Shiwei He, Sha Gong, et al.. (2024). LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein. Drug Resistance Updates. 76. 101111–101111. 7 indexed citations
7.
Li, Qian, Cheng Xu, Ye‐Lin Liang, et al.. (2023). Chemotherapy‐Induced Senescence Reprogramming Promotes Nasopharyngeal Carcinoma Metastasis by circRNA‐Mediated PKR Activation. Advanced Science. 10(8). e2205668–e2205668. 35 indexed citations
8.
Zhao, Yin, Sha Gong, Miaomiao Wang, et al.. (2023). TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models. Nature Communications. 14(1). 865–865. 73 indexed citations
9.
Long, Zhi‐Qing, Zi‐Qi Zheng, Lulu Zhang, et al.. (2023). m6A-enriched lncRNA LINC00839 promotes tumor progression by enhancing TAF15-mediated transcription of amine oxidase AOC1 in nasopharyngeal carcinoma. Journal of Biological Chemistry. 299(7). 104873–104873. 11 indexed citations
10.
Liang, Ye‐Lin, Yuan Zhang, Xi-Rong Tan, et al.. (2023). Insights from Long Noncoding RNAs into Cancer-immunity Cycle Regulation. 5(1). 13–28. 3 indexed citations
11.
Liang, Ye‐Lin, Cong Ding, Qian Li, et al.. (2023). A tumor microenvironment-associated circRNA predictor for tumor relapse and chemotherapy vulnerability in nasopharyngeal carcinoma. iScience. 26(12). 108467–108467. 4 indexed citations
12.
Zheng, Zi‐Qi, Ye‐Lin Liang, Cheng Xu, et al.. (2023). VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner. Journal of Biological Chemistry. 299(5). 104677–104677. 11 indexed citations
13.
Liang, Ye‐Lin, Yuan Zhang, Xu Liu, et al.. (2023). LINC00173 facilitates tumor progression by stimulating RAB1B‐mediated PA2G4 and SDF4 secretion in nasopharyngeal carcinoma. Molecular Oncology. 17(3). 518–533. 7 indexed citations
14.
Hong, Xiao-Hong, Kailin Chen, Qing‐Mei He, et al.. (2022). CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization. Clinical Cancer Research. 28(20). 4521–4535. 47 indexed citations
15.
Luo, Wei‐Jie, Yanfen Feng, Fang Liu, et al.. (2022). Expression Profiles and Prognostic Value of Multiple Inhibitory Checkpoints in Head and Neck Lymphoepithelioma-Like Carcinoma. Frontiers in Immunology. 13. 818411–818411. 6 indexed citations
16.
Hong, Xiao-Hong, Na Liu, Ye‐Lin Liang, et al.. (2020). Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1. Molecular Cancer. 19(1). 33–33. 159 indexed citations
17.
He, Shiwei, Cheng Xu, Ying-Qing Li, et al.. (2020). AR-induced long non-coding RNA LINC01503 facilitates proliferation and metastasis via the SFPQ-FOSL1 axis in nasopharyngeal carcinoma. Oncogene. 39(34). 5616–5632. 29 indexed citations
18.
Liang, Ye‐Lin, Junyan Li, Qian Li, et al.. (2020). Plasma protein-based signature predicts distant metastasis and induction chemotherapy benefit in Nasopharyngeal Carcinoma. Theranostics. 10(21). 9767–9778. 26 indexed citations
19.
Zhao, Yin, Kang Li, Ying‐Qin Li, et al.. (2020). ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin‐3 and NRXN3. Cancer Communications. 40(12). 721–737. 21 indexed citations
20.
Zhang, Yu, Wei Jiang, Yu‐Pei Chen, et al.. (2019). Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis. Journal for ImmunoTherapy of Cancer. 7(1). 298–298. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaozhi Lv Breakdown of academic impact, for papers by Yunhong Tian Breakdown of academic impact, for papers by Tianliang Xia Breakdown of academic impact, for papers by Hsuan-Yu Peng Breakdown of academic impact, for papers by Xinhua Xu Breakdown of academic impact, for papers by Madison Canning Breakdown of academic impact, for papers by Yixin Liu Breakdown of academic impact, for papers by Hiroko Kitahara Breakdown of academic impact, for papers by М. Р. Патышева Breakdown of academic impact, for papers by Maosheng Cheng
Rankless by CCL
2026